ONKOSXCEL THERAPEUTICS Trademark

Trademark Overview

On Friday, March 18, 2022, a trademark application was filed for ONKOSXCEL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ONKOSXCEL THERAPEUTICS trademark a serial number of 97319593. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, June 10, 2024. This trademark is owned by OnkosXcel Therapeutics, LLC. The ONKOSXCEL THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services; biopharmaceutical research services; pharmaceutical and biopharmaceutical products development; Pharmaceutical and biopharmaceutical drug development services; Development of pharmaceutical and biopharmaceutical preparations and medicines
onkosxcel therapeutics

General Information

Serial Number97319593
Word MarkONKOSXCEL THERAPEUTICS
Filing DateFriday, March 18, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, June 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research services; biopharmaceutical research services; pharmaceutical and biopharmaceutical products development; Pharmaceutical and biopharmaceutical drug development services; Development of pharmaceutical and biopharmaceutical preparations and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOnkosXcel Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew Haven, CT 06511
Party NameOnkosXcel Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Haven, CT 06511

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022NEW APPLICATION ENTERED
Wednesday, March 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Friday, December 30, 2022NON-FINAL ACTION E-MAILED
Friday, December 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 20, 2023SOU EXTENSION 1 FILED
Monday, January 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, January 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, March 22, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, March 22, 2024PETITION TO REVIVE-GRANTED
Friday, March 22, 2024NOTICE OF REVIVAL - E-MAILED
Friday, March 22, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, May 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 15, 2024SOU EXTENSION 1 GRANTED
Thursday, May 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 10, 2024SOU EXTENSION 2 GRANTED
Monday, June 10, 2024SOU EXTENSION 2 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics onkosxcel pharmaceutical biopharmaceutical development services research medicines preparations products drug